AstraZeneca reported plans to manufacture as much as 30 million doses of the University of Oxford’s COVID-19 vaccine for the U.K. market by September 2020, with expectations of 100 million doses by the end of the year.
The U.S. Centers for Disease Control and Prevention (CDC) plans a nationwide study of up to 325,000 people to track how the new coronavirus is spreading across the country into 2021 and beyond, a CDC spokeswoman and researchers conducting the effort told Reuters.
According to the World Health Organization and ClinicalTrials.gov, there are 1,114 ongoing clinical studies of treatments for COVID-19. A GlobalData analysis indicates that 21 of the trials have reported interim results, with 16 showing positive early results.
Patients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ .
Shares of Abbott Laboratories dipped in trading following reports of a new study showing that the company’s approved COVID-19 testing kits have fallen short in accurately detecting the novel coronavirus.
Sanofi chief executive Paul Hudson said it was vital that any coronavirus vaccine reach all regions, hours after the pharmaceutical giant was admonished by the French government for suggesting some countries would get priority access.
British researchers will study the genes of thousands of ill COVID-19 patients to try to crack one of the most puzzling riddles of the novel coronavirus: why does it kill some people but give others not even a mild headache?
